1. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
   Raefa Abou Khouzam et al, 2021, Frontiers in Immunology CrossRef
2. Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
   Esther Arnaiz et al, 2021, BMC Cancer CrossRef
3. The immunoreactivity of GLI1 and VEGFA is a potential prognostic factor in kidney renal clear cell carcinoma
   Anna Kotulak-Chrzaszcz et al, 2023, BMC Cancer CrossRef
4. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
   Kenan Zhang et al, 2022, Journal of Oncology CrossRef
5. MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
   Samuel Swearson et al, 2022, International Journal of Molecular Sciences CrossRef
6. Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia
   Monika Englert-Golon et al, 2022, Cancers CrossRef
7. FN1 and cancer‐associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma
   Gayathri Ashok et al, 2023, The Journal of Gene Medicine CrossRef
8. Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
   Sujin Park et al, 2023, Journal of Pathology and Translational Medicine CrossRef
9. Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art
   Michele Marchioni et al, 2021, Current Urology Reports CrossRef